Ross Weinreb
Stock Analyst at Goldman Sachs
(n/a)
# 4,975
Out of 5,123 analysts
3
Total ratings
n/a
Success rate
-45.51%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Ross Weinreb
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RLMD Relmada Therapeutics | Maintains: Buy | $69 → $53 | $3.60 | +1,372.22% | 3 | Mar 24, 2022 |
Relmada Therapeutics
Mar 24, 2022
Maintains: Buy
Price Target: $69 → $53
Current: $3.60
Upside: +1,372.22%